The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 1, 2003, Pages 48-56

  Ryu, Bo Rum ^a   Lee, Young Ae ^a   Won, Seok Joon ^a   Noh, Ji Hyun ^b   Chang, Su Youne ^b   Chung, Jun Mo ^b   Choi, Jun Sub ^c   Joo, Choun Ki ^c   Yoon, Sung Hwa ^d   Gwag, Byoung Joo ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SALAZOSULFAPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; INFLAMMATORY CELL; MEDIATOR RELEASE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RETINA ISCHEMIA;

ANIMALS; ANTIOXIDANTS; CALCIUM; CELLS, CULTURED; CEREBRAL CORTEX; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ISCHEMIA; ISOENZYMES; MALE; MICE; MICE, INBRED ICR; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL DISEASES; SULFASALAZINE;

EID: 0037381517     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.042606     Document Type: Article

References (53)

1. Aruoma OI, Wasil M, Halliwell B, Hoey BM, and Butler J (1987) The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol 36:3739-3742.
2. Aubin N, Curet O, Deffois A, and Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71:1635-1642.
3. Baeuerle PA and Baltimore D (1996) NF-κB: ten years after. Cell 87:13-20.
4. Barneoud P and Curet O (1999) Beneficial effects oflysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp Neurol 155:243-251.
5. Beg AA and Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Wash DC) 274:782-784.
6. Bezanilla F and Armstrong CM (1977) Inactivation of the sodium channel. I. Sodium current experiments, J Gen Physiol 70:549-566.
7. Boissiere F, Hunot S, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y, and Hirsch EC (1997) Nuclear translocation of NF-κB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8:2849-2852.
8. Choi DW (1987) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
9. Choi DW and Rothman SM (1990) The role of glutamate neurotoxicity in hypoxicischemic neuronal death. Annu Rev Neurosci 13:171-182.
10. Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS, and Little SP (1997) Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 48:187-196.
11. Dash PK, Mach SA, and Moore AN (2000) Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J Neurotrauma 17:69-81.
12. Davis SM, Albers GW, Diener HC, Lees KR, and Norris J (1997) Termination of acute stroke studies involving selfotel treatment. Assist steering committed. Lancet 349:32.
13. Diez-Tejedor E, Alonso de Lecinana M, Counsell C, and Sandercock P (1995) Antithrombotic treatment in acute ischemia stroke. Neurologia 10:48-54.
14. Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin TS, Goldberg MP, and Choi DW (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 15:6377-6388.
15. Grilli M, Pizzi M, Memo M, and Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science (Wash DC) 274: 1383-1385.
16. Gwag BJ, Koh JY, Chen MM, Dugan LL, Behrens MM, Lobner D, and Choi DW (1995) BDNF or IGF-I potentiates free radical-mediated injury in cortical cell cultures. Neuroreport 7:93-96.
17. Halliwell RF, Peters JA, and Lambert JJ (1989) The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture. Br J Pharmacol 96:480-494.
18. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J Neurosci 13:1993-2000.
19. Hennekens CH, Peto R, Hutchison GB, and Doll R (1988) An overview of the ofthe British and American aspirin studies. N Engl J Med 318:923-924.
20. Hewett SJ, Uliasz TF, Vidwans AS, and Hewett JA (2000) Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293:417-425.
21. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, and Ross ME (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98:1294-1299.
22. Joo CK, Choi JS, Ko HW, Park KY, Sohn S, Chun MH, Oh YJ, and Gwag BJ (1999) Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Investig Ophthalmol Vis Sci 40:713-720.
23. Khayyam N, Thavendiranathan P, Carmichael FJ, Kus B, Jay V, and Burnham WM (1999) Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. Neuroreport 10:371-374.
24. 2+ channel and the carboxyl acid group. Neurobiol Dis 8:774-783.
25. 2+-mediated activation of c-Jun N-terminal kinase and nuclear factor-κB by NMDA in cortical cell cultures. J Neurochem 71:1390-1395.
26. Kopp E and Ghosh S (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science (Wash DC) 265:956-959.
27. Lees KR (1997) Cerestat and other NMDA antagonists in ischemic stroke. Neurology 49:S66-S69.
28. Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K (1997) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49:681-697.
29. Muir KW and Lees KR (1995) Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513.
30. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, Isakson PC, Chen J, and Graham SH (1998) Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 95:10954-10959.
31. Oka A and Takashima S (1997) Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. Neuroreport 8:1161-1164.
32. Olney JW, Labruyere J, and Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (Wash DC) 244:1360-1362.
33. O'Neill LA and Kaltschmidt C (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258.
34. Planas AM, Soriano MA, Rodriguez-Farre E, and Ferrer I (1995) Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci Lett 200:187-190.
35. Qin ZH, Wang Y, Nakai M, and Chase TN (1998) Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum. Mol Pharmacol 53:33-42.
36. Resnick DK, Graham SH, Dixon CE, and Marion DW (1998) Role of cyclooxygenase 2 in acute spinal cord injury. J Neurotrauma 15:1005-1013.
37. Reynolds JEF (1996) Martindale, The Extra Pharamcopoeia, 31st ed, Royal Pharmaceutical Society, London.
38. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, and Brandt J (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55.
39. Rogawski MA (2000) Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability. Amino Acids (Vienna) 19:133-149.
40. Ryu BR, Ko HW, Jou I, Noh JS, and Gwag BJ (1999) Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol 39:536-546.
41. Sasaki T, Nakagomi T, Kirino T, Tamura A, Noguchi M, Saito I, and Takakura K (1988) Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector. Stroke 19:1399-1403.
42. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, and Giachelli CM (1998) NF-κB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083-1093.
43. Schroder H and Campbell DE (1972) Absorption, metabolism and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 13:539-551.
44. Sengpiel B, Preis E, Krieglstein J, and Prehn JH (1998) NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci 10:1903-1910.
45. Seo SY, Kim EY, Kim H, Jou I, and Gwag BJ (1999) Attenuation of neuronal death by NMDA and oxygen-glucose deprivation in cortical neurons maintained in high glucose. Ann NY Acad Sci 893:396-399.
46. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, and Clemens J (2000) Transcription factor nuclear factor-κB is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 20:592-603.
47. Svartz N (1942) Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 110:577-598.
48. Taglialatela G, Robinson R, and Perez-Polo JR (1997) Inhibition of nuclear factor-κB (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 47:155-162.
49. Tamura A, Graham DI, McCulloch J, and Teasdale GM (1981) Focal cerebral ischaemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60.
50. Vane JR and Botting RM (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104:2S-8S.
51. Wahl C, Liptay S, Adler G, and Schmid RM (1998) Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Investig 101:1163-1174.
52. Won SJ, Ko HW, Kim EY, Park EC, Huh K, Jung NP, Choi I, Oh YK, Shin HC, and Gwag BJ (1999) Nuclear factor-κB-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience 94:83-91.
53. 2+-activated nonselective cation channels in neuroblastoma. Nature (Lond) 296:357-359.